Who owns Insmed (INSM)? Superinvestor holders
7 superinvestors of the 157 tracked here hold Insmed (INSM) in their latest 13F filing, with $2.5B between them. Julian and Felix Baker gives it the most weight: 4.70% of the reported portfolio. In their latest reported quarter, Lee Ainslie opened a position; Julian and Felix Baker, Stanley Druckenmiller, David Shaw (founder) and Ray Dalio (founder) and 2 more added.
Ron Baron sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 7 of 157
- Biggest holder
- Julian and Felix Baker, $937.8M
- Largest weight
- Julian and Felix Baker, 4.70%of their portfolio
- Combined value
- $2.5B
- Bought last quarter
- 7
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Julian and Felix BakerBaker Bros. Advisors | 4.70% | $937.8M | 8.8M | ▲ Added 19% | +1.38M | Q2 2026 |
| 2 | Stanley DruckenmillerDuquesne Family Office | 3.49% | $151.9M | 1.42M | ▲ Added 23% | +270.63K | Q2 2026 |
| 3 | Lee AinslieMaverick Capital | 2.07% | $229.3M | 2.15M | New | +2.15M | Q2 2026 |
| 4 | David Shaw (founder)D. E. Shaw & Co. | 0.39% | $626.7M | 5.88M | ▲ Added 4.5% | +252.04K | Q2 2026 |
| 5 | Ray Dalio (founder)Bridgewater Associates | 0.20% | $48.6M | 455.39K | ▲ Added 54% | +159.82K | Q2 2026 |
| 6 | Ken GriffinCitadel Advisors | 0.16% | $272.6M | 2.56M | ▲ Added 17% | +374.32K | Q2 2026 |
| 7 | Israel EnglanderMillennium Management | 0.15% | $218.4M | 2.05M | ▲ Added 77% | +890.22K | Q2 2026 |
Sold out last quarter
- Ron Baronwas $1.1M · Q3 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 0 | — | — | 0 | 1 |
| Q2 2026 | 157 | 7 | 23.31M | $2.5B | 7 | 0 |
| Q1 2026 | 157 | 6 | 17.84M | $2.9B | 4 | 5 |
| Q4 2025 | 157 | 7 | 15.5M | $2.7B | 1 | 8 |
| Q3 2025 | 157 | 9 | 21.42M | $3.1B | 4 | 3 |
| Q2 2025 | 157 | 8 | 18.83M | $1.9B | 6 | 3 |
| Q1 2025 | 156 | 7 | 9.71M | $740.9M | 4 | 2 |
| Q4 2024 | 156 | 6 | 6.38M | $440.4M | 3 | 1 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Julian and Felix Baker | · | 8.8M | 7.42M | 6.59M | 6.7M | 7.71M | 5.38M | 5.01M |
| David Shaw (founder) | · | 5.88M | 5.63M | 4.35M | 5.66M | 3.42M | — | — |
| Ken Griffin | · | 2.56M | 2.18M | — | 2.06M | — | — | — |
| Lee Ainslie | · | 2.15M | — | — | 656.54K | 804.13K | 425.13K | — |
| Israel Englander | · | 2.05M | 1.16M | 1.31M | 2.34M | 2.12M | — | — |
| Stanley Druckenmiller | · | 1.42M | 1.15M | 1.48M | 2.42M | 2.25M | 1.37M | 593.47K |
| Ray Dalio (founder) | · | 455.39K | 295.58K | — | — | — | — | — |
| John Overdeck and David Siegel (founders) | — | — | — | 962.16K | — | — | — | — |
| Brandon Haley | · | — | — | 801.17K | 1.08M | 2.02M | 2.03M | — |
| Andrew Spokes | — | — | — | 3K | 3K | 3K | 3K | 3K |
| Takis Sparaggis | — | — | — | — | 500K | 500K | — | — |
| George Soros | — | — | — | — | — | — | 307.21K | 455.09K |
| Peter Kolchinsky | · | — | — | — | — | — | 200K | 200K |
| Doug Silverman | — | — | — | — | — | — | — | 120K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own INSM?
In their latest 13F filings: Julian and Felix Baker (4.70% of the portfolio, $937.8M), Stanley Druckenmiller (3.49% of the portfolio, $151.9M), Lee Ainslie (2.07% of the portfolio, $229.3M), David Shaw (founder) (0.39% of the portfolio, $626.7M), Ray Dalio (founder) (0.20% of the portfolio, $48.6M), Ken Griffin (0.16% of the portfolio, $272.6M), Israel Englander (0.15% of the portfolio, $218.4M).
Who bought INSM last quarter?
Julian and Felix Baker (added 19%), Stanley Druckenmiller (added 23%), Lee Ainslie (new position), David Shaw (founder) (added 4.5%), Ray Dalio (founder) (added 54%), Ken Griffin (added 17%), Israel Englander (added 77%). “Last quarter” is each investor's latest reported quarter.
Who sold INSM last quarter?
Sold out entirely: Ron Baron (was $1.1M).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Insmed (INSM)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/INSM/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to INSM by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.